Kaya Holdings Inc
OTC:KAYS
Kaya Holdings Inc
OTC:KAYS
Price:
0.0315
USD
Market Closed
Market Cap:
$21.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kaya Holdings Inc
OTC:KAYS
|
US |
|
L
|
logly Inc
TSE:6579
|
JP |
|
Tsukui Staff Corp
TSE:7045
|
JP |
|
V
|
Vicem Energy and Environment JSC
VN:VTV
|
VN |
|
Schumag AG
F:SCM
|
DE |
|
Muromachi Chemicals Inc
TSE:4885
|
JP |
|
C
|
Coca-Cola Femsa SAB de CV
F:CFSL
|
MX |
|
T
|
Tobii Dynavox AB
STO:TDVOX
|
SE |
|
C
|
China National Building Material Co Ltd
HKEX:3323
|
CN |
|
P
|
Paion AG
XHAM:PA8
|
DE |
|
Delta 9 Cannabis Inc
TSX:DN
|
CA |
|
Gibus SpA
MIL:GBUS
|
IT |
|
U
|
Unlimited Travel Group UTG AB (publ)
STO:UTG
|
SE |
Multiples-Based Value
The
Multiples-Based Value for
Kaya Holdings Inc (KAYS)
under the Base Case is
hidden
USD.
Compared with the current market price of 0.0315 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KAYS Multiples-Based Value
LOCKED
Multiples Across Competitors
KAYS Competitors Multiples
Kaya Holdings Inc Competitors
Kaya Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Kaya Holdings Inc
OTC:KAYS
|
21.6m USD | 956.8 | -1.7 | -30.1 | -29.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6 | 27.3 | 17.5 | 22.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.3 | 12.6 | 16.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.8 | 11.3 | 8.3 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
